Basilea to continue late-stage antifungal study (Reuters) » MyHealthPortal.com :: Health information on diabetes, cancer, heart disease, arthritis and etc.

Basilea to continue late-stage antifungal study (Reuters)

Reuters - Swiss biotechnology group Basilea said it would resume recruitment of patients into a late-stage trial of an antifungal treatment in the first half of 2010 after a U.S. safety panel recommended the study's continuation.

(Votes #: 0)

Dear visitor, You have entered on a site as not registered user. We recommend you to be registered or to enter on a site under the your username.

Other News:

Roche arthritis drug effective in late-stage study (Reuters)

New diabetes drug hits target in late stage study (Reuters)

New Obesity Drug Qnexa Showed Positive Results In Late Stage Trials Test Sa ...

Shares tumble as Bioxell lead drug fails in trial (Reuters)

« March 2010 »